Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 The adverse events of chemotherapy for retinoblastoma: what are they? Do we know?

Literature DB >> 18541855

The adverse events of chemotherapy for retinoblastoma: what are they? Do we know?

Allison E Rizzuti, Ira J Dunkel, David H Abramson.

Abstract

Entities: Disease

Mesh：

Substances：
Antineoplastic Agents

Year: 2008 PMID： 18541855 DOI： 10.1001/archopht.126.6.862

Source DB: PubMed Journal: Arch Ophthalmol ISSN： 0003-9950

Keyword Cloud
Cited

× No keyword cloud information.

18 in total

1. In vitro evaluation of a targeted and sustained release system for retinoblastoma cells using Doxorubicin as a model drug.

Authors: Sai H S Boddu; Jwala Jwala; Monica R Chowdhury; Ashim K Mitra
Journal: J Ocul Pharmacol Ther Date: 2010-10 Impact factor: 2.671

2. Sonoporation enhances chemotherapeutic efficacy in retinoblastoma cells in vitro.

Authors: Nahyoung G Lee; Jesse L Berry; Tom C Lee; Annie T Wang; Scott Honowitz; A Linn Murphree; Neeta Varshney; David R Hinton; Amani A Fawzi
Journal: Invest Ophthalmol Vis Sci Date: 2011-06-01 Impact factor: 4.799

3. Selective ophthalmic arterial injection of melphalan for intraocular retinoblastoma: a 4-year review.

Authors: Sherine Jue Ong; An-Ning Chao; Ho-Fai Wong; Kuan-Lyin Liou; Ling-Yuh Kao
Journal: Jpn J Ophthalmol Date: 2014-12-03 Impact factor: 2.447

4. Intra-arterial chemotherapy as a treatment for intraocular retinoblastoma: alternatives to direct ophthalmic artery catheterization.

Authors: M A Klufas; Y P Gobin; B Marr; S E Brodie; I J Dunkel; D H Abramson
Journal: AJNR Am J Neuroradiol Date: 2012-03-22 Impact factor: 3.825

5. Low-Dose Chemoreduction for Infants Diagnosed with Retinoblastoma before 6 Months of Age.

Authors: Jesse L Berry; Rima Jubran; Thomas C Lee; A Linn Murphree; Diana Lee; Jonathan W Kim
Journal: Ocul Oncol Pathol Date: 2015-01-16

6. Tandem therapy for retinoblastoma: immunotherapy and chemotherapy enhance cytotoxicity on retinoblastoma by increasing apoptosis.

Authors: Qiuling Liu; Yafeng Wang; Han Wang; Yingying Liu; Tao Liu; Patricia Elena Kunda
Journal: J Cancer Res Clin Oncol Date: 2013-05-21 Impact factor: 4.553

7. In human retinoblastoma Y79 cells okadaic acid-parthenolide co-treatment induces synergistic apoptotic effects, with PTEN as a key player.

Authors: Riccardo Di Fiore; Rosa Drago-Ferrante; Antonella D'Anneo; Giuseppa Augello; Daniela Carlisi; Anna De Blasio; Michela Giuliano; Giovanni Tesoriere; Renza Vento
Journal: Cancer Biol Ther Date: 2013-08-12 Impact factor: 4.742